Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.

Abstract:

:The heterogeneous breast cancers can be classified into different subtypes according to their histopathological characteristics and molecular signatures. Foxa1 expression is linked with luminal breast cancer (LBC) with good prognosis, whereas Twist1 expression is associated with basal-like breast cancer (BLBC) with poor prognosis owing to its role in promoting epithelial-to-mesenchymal transition (EMT), invasiveness and metastasis. However, the regulatory and functional relationships between Twist1 and Foxa1 in breast cancer progression are unknown. In this study, we demonstrate that in the estrogen receptor (ERα)-positive LBC cells Twist1 silences Foxa1 expression, which has an essential role in relieving Foxa1-arrested migration, invasion and metastasis of breast cancer cells. Mechanistically, Twist1 binds to Foxa1 proximal promoter and recruits the NuRD transcriptional repressor complex to de-acetylate H3K9 and repress RNA polymerase II recruitment. Twist1 also silences Foxa1 promoter by inhibiting AP-1 recruitment. Twist1 expression in MCF7 cells silenced Foxa1 expression, which was concurrent with the induction of EMT, migration, invasion and metastasis of these cells. Importantly, restored Foxa1 expression in these cells largely inhibited Twist1-promoted migration, invasion and metastasis. Restored Foxa1 expression did not change the Twist1-induced mesenchymal cellular morphology and the expression of Twist1-regulated E-cadherin, β-catenin, vimentin and Slug, but it partially rescued Twist1-silenced ERα and cytokeratin 8 expression and reduced Twist1-induced integrin α5, integrin β1 and MMP9 expression. In a xenografted mouse model, restored Foxa1 also increased Twist1-repressed LBC markers and decreased Twist1-induced BLBC markers. Furthermore, Twist1 expression is negatively correlated with Foxa1 in the human breast tumors. The tumors with high Twist1 and low Foxa1 expressions are associated with poor distant metastasis-free survival. These results demonstrate that Twist1's silencing effect on Foxa1 expression is largely responsible for Twist1-induced migration, invasion and metastasis, but less responsible for Twist1-induced mesenchymal morphogenesis and expression of certain EMT markers.

journal_name

Oncogene

journal_title

Oncogene

authors

Xu Y,Qin L,Sun T,Wu H,He T,Yang Z,Mo Q,Liao L,Xu J

doi

10.1038/onc.2016.286

subject

Has Abstract

pub_date

2017-02-23 00:00:00

pages

1157-1166

issue

8

eissn

0950-9232

issn

1476-5594

pii

onc2016286

journal_volume

36

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • IL-6-independent expression of Mcl-1 in human multiple myeloma.

    abstract::Mcl-1 is a critical antiapoptotic survival factor for human multiple myeloma (MM). We examined the importance of IL-6 for Mcl-1 expression in five MM cell lines and in primary MM cells from 14 patients. While culture of MM.1S cells in IL-6 did induce Mcl-1 expression, four other MM cell lines exhibited high levels of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206358

    authors: Zhang B,Potyagaylo V,Fenton RG

    更新日期:2003-03-27 00:00:00

  • Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.

    abstract::Hepatitis B virus (HBV)-induced liver necrosis takes great part in liver cirrhosis progression. However, less is known about whether hepatitis B virus X protein (HBx) has effect on liver fibrosis. Here, we report that HBV leads to liver fibrosis and hepatocarcinogenesis through miR-30e targeting P4HA2. HBV transgenic ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.291

    authors: Feng GX,Li J,Yang Z,Zhang SQ,Liu YX,Zhang WY,Ye LH,Zhang XD

    更新日期:2017-12-14 00:00:00

  • MFG-E8/lactadherin regulates cyclins D1/D3 expression and enhances the tumorigenic potential of mammary epithelial cells.

    abstract::Milk fat globule-EGF factor 8 (MFG-E8) is a glycoprotein highly expressed in breast cancer that contributes to tumor progression through largely undefined mechanisms. By analyzing publicly available gene expression profiles of breast carcinomas, we found that MFG-E8 is highly expressed in primary and metastatic breast...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.356

    authors: Carrascosa C,Obula RG,Missiaglia E,Lehr HA,Delorenzi M,Frattini M,Rüegg C,Mariotti A

    更新日期:2012-03-22 00:00:00

  • Reciprocal relationship in gene expression between FGFR1 and FGFR3: implication for tumorigenesis.

    abstract::We have previously demonstrated that the expression of FGFR3 is frequently downregulated in colorectal carcinoma cells. Here we have shown that FGFR1 is overexpressed in colorectal carcinoma cells and the gene expressions between FGFR1 and FGFR3 are mutually exclusive. Moreover, we have also shown that the disruption ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208254

    authors: Jang JH

    更新日期:2005-01-27 00:00:00

  • Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.

    abstract::beta-catenin activation, and subsequent upregulation of Wnt-signaling, is an important event in the development of certain human and rodent cancers. Recently, mutations in the beta-catenin gene in the region of the serine-threonine glycogen kinase (GSK)-3beta phosphorylation target sites have been identified in hepato...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202858

    authors: Devereux TR,Anna CH,Foley JF,White CM,Sills RC,Barrett JC

    更新日期:1999-08-19 00:00:00

  • In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation.

    abstract::c-Myc drives uncontrolled cell proliferation in various human cancers. However, in mouse embryo fibroblasts (MEFs), c-Myc also induces apoptosis by activating the p19Arf tumor suppressor pathway. Tbx2, a transcriptional repressor of p19Arf, can collaborate with c-Myc by suppressing apoptosis. MEFs overexpressing c-Myc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.294

    authors: Taghavi P,Verhoeven E,Jacobs JJ,Lambooij JP,Stortelers C,Tanger E,Moolenaar WH,van Lohuizen M

    更新日期:2008-11-20 00:00:00

  • p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.

    abstract::Mutations in the p53 tumour suppressor gene have been recently described in hepatocellular carcinomas (HCC) from high risk areas such as China and South Africa. Our study was designed to assess the importance of p53 aberrations in HCCs from Europe, where the major risk factors in hepatocarcinogenesis, aflatoxin exposu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Volkmann M,Hofmann WJ,Müller M,Räth U,Otto G,Zentgraf H,Galle PR

    更新日期:1994-01-01 00:00:00

  • Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance.

    abstract::We have shown that one of the principle mechanisms of chemotherapy resistance involves the activation of nuclear factor kappa-B (NF-kappaB). In an effort to identify NF-kappaB-regulated chemotherapy response genes, we performed a microarray assay and observed that heparin-binding EGF-like growth factor (HB-EGF) was si...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209999

    authors: Wang F,Liu R,Lee SW,Sloss CM,Couget J,Cusack JC

    更新日期:2007-03-29 00:00:00

  • The BPV-4 co-carcinogen quercetin induces cell cycle arrest and up-regulates transcription from the LCR of BPV-4.

    abstract::Bracken fern is the environmental co-carcinogen of BPV-4 in the induction of neoplasias of the upper alimentary canal of cattle. The flavonoid quercetin is one of the most potent and best characterised mutagens present in the fern. We have shown that transfection with BPV-4 DNA and exposure to a single dose of quercet...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201796

    authors: Connolly JA,Morgan IM,Jackson ME,Campo MS

    更新日期:1998-05-28 00:00:00

  • Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway.

    abstract::Hypoxic microenvironment supports cancer stem cell survival, causes poor response to anticancer therapy and tumor recurrence. Inhibition of Notch-1 signaling in adenocarcinoma of the lung (ACL) cells causes apoptosis specifically under hypoxia. Here, we found that Akt-1 activation is a key mediator of Notch-1 pro-surv...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.7

    authors: Eliasz S,Liang S,Chen Y,De Marco MA,Machek O,Skucha S,Miele L,Bocchetta M

    更新日期:2010-04-29 00:00:00

  • Repression of hepatitis B virus (HBV) transgene and HBV-induced liver injury by low protein diet.

    abstract::Persistent infection with hepatitis B virus (HBV) is one of the primary risk factors for human hepatocellular carcinoma (HCC). In a human ecological study, we have shown that, in addition to HBV, animal food consumption also significantly contributes to the variance of HCC. To test the interacting effect of HBV and an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201444

    authors: Hu JF,Cheng Z,Chisari FV,Vu TH,Hoffman AR,Campbell TC

    更新日期:1997-12-04 00:00:00

  • Mutation of GATA3 in human breast tumors.

    abstract::GATA3 is an essential transcription factor that was first identified as a regulator of immune cell function. In recent microarray analyses of human breast tumors, both normal breast luminal epithelium and estrogen receptor (ESR1)-positive tumors showed high expression of GATA3. We sequenced genomic DNA from 111 breast...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207966

    authors: Usary J,Llaca V,Karaca G,Presswala S,Karaca M,He X,Langerød A,Kåresen R,Oh DS,Dressler LG,Lønning PE,Strausberg RL,Chanock S,Børresen-Dale AL,Perou CM

    更新日期:2004-10-07 00:00:00

  • Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.

    abstract::The RAS-RAF-MEK-ERK signaling cascade is among the most frequently mutated pathways in human cancer. Approximately 50% of melanoma patients possess a druggable hotspot V600E/K mutation in the BRAF protein kinase. FDA-approved combination therapies of BRAF and MEK inhibitors are available that provide survival benefits...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-018-0171-x

    authors: Dankner M,Rose AAN,Rajkumar S,Siegel PM,Watson IR

    更新日期:2018-06-01 00:00:00

  • RB and cell cycle progression.

    abstract::The Rb protein is a tumor suppressor, which plays a pivotal role in the negative control of the cell cycle and in tumor progression. It has been shown that Rb protein (pRb) is responsible for a major G1 checkpoint, blocking S-phase entry and cell growth. The retinoblastoma family includes three members, Rb/p105, p107 ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209615

    authors: Giacinti C,Giordano A

    更新日期:2006-08-28 00:00:00

  • MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.

    abstract::The identification of target mRNAs is a key step for assessing the role of aberrantly expressed microRNAs in human cancer. MiR-221 is upregulated in human hepatocellular carcinoma (HCC) as well as in other malignancies. One proven target of miR-221 is CDKN1B/p27, whose downregulation affects HCC prognosis. Here, we pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.178

    authors: Fornari F,Gramantieri L,Ferracin M,Veronese A,Sabbioni S,Calin GA,Grazi GL,Giovannini C,Croce CM,Bolondi L,Negrini M

    更新日期:2008-09-25 00:00:00

  • Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis.

    abstract::Colitis-associated colorectal cancers are an etiologically distinct subgroup of colon cancers that occur in individuals suffering from inflammatory bowel disease and arise as a consequence of persistent exposure of hyperproliferative epithelial stem cells to an inflammatory microenvironment. An intrinsic defect in the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.545

    authors: Kosa P,Szabo R,Molinolo AA,Bugge TH

    更新日期:2012-08-09 00:00:00

  • MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8.

    abstract::Genetic amplification at chromosome 8p23.1 has been reported in some solid tumors. Translocation of 8p23.1 has also been reported in hematological malignancies and head and neck squamous cell cancer. In an attempt to clarify whether this translocation is implicated in lymphomagenesis, we performed FISH analysis of the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207352

    authors: Tagawa H,Karnan S,Kasugai Y,Tuzuki S,Suzuki R,Hosokawa Y,Seto M

    更新日期:2004-04-01 00:00:00

  • The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells.

    abstract::High-risk papillomavirus type 18 (HPV18) is one of the less represented HPV types in low-grade lesions of the anogenital tract, whereas it occupies the second place in cervical cancer, where it can be found in 16% of the cases worldwide, after HPV16 present in 54% of them. These epidemiological data indicate that HPV1...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.246

    authors: Teissier S,Pang CL,Thierry F

    更新日期:2010-09-09 00:00:00

  • Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells.

    abstract::We have previously demonstrated that daunorubicin (DNR) induces apoptosis in some leukemic myeloid cell lines. We investigated a potential protective role for Bcl-2 in apoptosis induced by DNR in two leukemic cell lines, one myeloid and one lymphoid, overexpressing the anti-apoptotic gene Bcl-2. Parental cells treated...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201023

    authors: Allouche M,Bettaieb A,Vindis C,Rousse A,Grignon C,Laurent G

    更新日期:1997-04-17 00:00:00

  • G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells.

    abstract::Inhibition of telomerase activity by telomerase inhibitors induces a gradual loss of telomeres, and this in turn causes cancer cells to enter to a crisis stage. Here, we report the telomerase inhibitor telomestatin, which is known to stabilize G-quadruplex structures at 3' single-stranded telomeric overhangs (G-tails)...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209217

    authors: Tahara H,Shin-Ya K,Seimiya H,Yamada H,Tsuruo T,Ide T

    更新日期:2006-03-23 00:00:00

  • Cell context reveals a dual role for Maf in oncogenesis.

    abstract::Maf b-Zip transcription factors are involved in both terminal differentiation and oncogenesis. To investigate this apparent contradiction, we used two different primary cell types and performed an extensive analysis of transformation parameters induced by Maf proteins. We show that MafA and c-Maf are potent oncogenes ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209171

    authors: Pouponnot C,Sii-Felice K,Hmitou I,Rocques N,Lecoin L,Druillennec S,Felder-Schmittbuhl MP,Eychène A

    更新日期:2006-03-02 00:00:00

  • Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.

    abstract::Like other types of pre-malignant lesions and carcinoma, angiogenesis is associated with high-grade cervical dysplasia and with invasive squamous carcinoma of the cervix. Vascular endothelial cell growth factor (VEGF) is known to be one of the most important inducers of angiogenesis and is upregulated in carcinoma of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203817

    authors: López-Ocejo O,Viloria-Petit A,Bequet-Romero M,Mukhopadhyay D,Rak J,Kerbel RS

    更新日期:2000-09-21 00:00:00

  • A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation.

    abstract::The 5' untranslated region of the proto-oncogene c-myc contains an internal ribosome entry segment (IRES) (Nanbru et al., 1997; Stoneley et al., 1998) and thus c-myc protein synthesis can be initiated by a cap-independent as well as a cap-dependent mechanism (Stoneley et al., 2000). In cell lines derived from patients...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203791

    authors: Chappell SA,LeQuesne JP,Paulin FE,deSchoolmeester ML,Stoneley M,Soutar RL,Ralston SH,Helfrich MH,Willis AE

    更新日期:2000-09-07 00:00:00

  • Inhibition of crystallin expression and induction of apoptosis by lens-specific E1A expression in transgenic mice.

    abstract::Previous studies have shown that the adenovirus E1A oncoprotein can bind to and inactivate the retinoblastoma tumor suppressor protein (pRb) and the transcriptional coactivators CBP/p300. In this study, wild-type E1A12S or two deletion mutants (delN, which binds pRb but not CBP/p300; delCR2, which binds to CBP/p300 bu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205050

    authors: Chen Q,Ash JD,Branton P,Fromm L,Overbeek PA

    更新日期:2002-02-07 00:00:00

  • The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.

    abstract::EndoA is a type II keratin and with EndoB (type I keratin), constitutes intermediate filaments in various simple epithelial tissues. EndoA is developmentally regulated and has an enhancer that is located at the 3'- end of the gene. This enhancer contains two single and five dual Ets binding sites. Thus far, no other p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Seth A,Robinson L,Panayiotakis A,Thompson DM,Hodge DR,Zhang XK,Watson DK,Ozato K,Papas TS

    更新日期:1994-02-01 00:00:00

  • DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway.

    abstract::Wnt signaling plays an important role in embryonic development and tumorigenesis. These biological effects are exerted by activation of the beta-catenin/TCF transcription complex and consequent regulation of a set of downstream genes. TCF-binding elements have been found in the promoter regions of many TCF target gene...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207892

    authors: Niida A,Hiroko T,Kasai M,Furukawa Y,Nakamura Y,Suzuki Y,Sugano S,Akiyama T

    更新日期:2004-11-04 00:00:00

  • Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.

    abstract::In breast cancer (BC) patients, local recurrences often arise in proximity of the surgical scar, suggesting that response to surgery may have a causative role. Radiotherapy (RT) after lumpectomy significantly reduces the risk of recurrence. We investigated the direct effects of surgery and of RT delivered intraoperati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.23

    authors: Fabris L,Berton S,Citron F,D'Andrea S,Segatto I,Nicoloso MS,Massarut S,Armenia J,Zafarana G,Rossi S,Ivan C,Perin T,Vaidya JS,Avanzo M,Roncadin M,Schiappacassi M,Bristow RG,Calin G,Baldassarre G,Belletti B

    更新日期:2016-09-15 00:00:00

  • Activation and repression of p21(WAF1/CIP1) transcription by RB binding proteins.

    abstract::The Cdk inhibitor p21(WAF1/CIP1) is a negative regulator of the cell cycle, although its expression is induced by a number of mitogens that promote cell proliferation. We have found that E2F1 and E2F3, transcription factors that activate genes required for cell cycle progression, are strong activators of the p21 promo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202240

    authors: Gartel AL,Goufman E,Tevosian SG,Shih H,Yee AS,Tyner AL

    更新日期:1998-12-31 00:00:00

  • Polymorphisms in the p53 pathway.

    abstract::The p53 tumor suppressor gene continues to be distinguished as the most frequently mutated gene in human cancer; this gene can be found mutated in up to 50% of human tumors of diverse histological type. It is generally accepted that the ability of p53 to induce either growth arrest or programmed cell death in response...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209367

    authors: Pietsch EC,Humbey O,Murphy ME

    更新日期:2006-03-13 00:00:00

  • K120R mutation inactivates p53 by creating an aberrant splice site leading to nonsense-mediated mRNA decay.

    abstract::The point mutation that substitutes lysine with arginine at position 120 of human p53 has been characterized as a missense mutation. The K120R mutation renders the p53 protein disabled for acetylation and, as a result, defective for apoptotic function, which provides a mechanistic link between the missense mutation an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0542-3

    authors: Lee SY,Park JH,Jeong S,Kim BY,Kang YK,Xu Y,Chung SK

    更新日期:2019-03-01 00:00:00